MedTrace Logo

Calypso Knee System Clinical Study, OUS

NCT03838978 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2025-04-10

Study results available
· View outcomes & findings →

Summary

A study to evaluate the safety and effectiveness of the Calypso Knee System when used in subjects with symptomatic osteoarthritis of the medial compartment of the knee.

Conditions

  • Osteoarthritis, Knee

Interventions

DEVICE

Calypso Knee System (Implantable Shock Absorber)

The Calypso Knee System is an extra-capsular knee implant designed to fill the therapeutic gap between conservative care and more invasive surgical interventions for knee osteoarthritis.

Sponsors & Collaborators

  • Moximed

    lead INDUSTRY

Principal Investigators

  • David Flanigan, MD · Ohio State University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-08
Primary Completion
2022-01-17
Completion
2025-03-14
FDA Device
Yes

Countries

  • Belgium
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03838978 on ClinicalTrials.gov